Articles

  • Jun 1, 2023 | ascopubs.org | Corey Speers |William E. Barlow |W. Fraser Symmans

    We appreciate the interest of Sui et al1 in our recent report2 and agree that SET 2,3 and many other tumor biomarker tests rely on averaged gene expression from a mixed population of cells, including malignant tumor cells, tumor-associated immune cells, stromal tissue, and endothelial cells. These tests, of necessity, are unable to get at the spatial and microenvironment-related heterogeneity that exists.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →